Search | Page 7 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. The clinical, quality of life, and economic consequences of chronic anemia and transfusion support in patients with myelodysplastic syndromes

    ... risks associated with transfusions, chronic anemia and red blood cell (RBC) transfusion dependence impact negatively on survival and ...

    Research Article last updated 06/15/2012 - 2:03pm.

  2. Prospective assessment of effects on iron-overload parameters of deferasirox therapy in patients with myelodysplastic syndromes.

    ... 24 and 52 weeks of therapy despite ongoing receipt of red blood cell transfusions. ...

    Research Article last updated 10/11/2011 - 5:58pm.

  3. Myelodysplastic syndromes and the role of iron overload.

    ... in patients with MDS due to the long-term use of red blood cell transfusions in patients with symptomatic anemia . ...

    Research Article last updated 10/11/2011 - 5:58pm.

  4. Durable long-term responses in patients with myelodysplastic syndromes treated with lenalidomide.

    ... Five of these patients had an ongoing requirement for red blood cell transfusions despite previous treatment with recombinant ...

    Research Article last updated 10/11/2011 - 5:58pm.

  5. A novel marker for screening paroxysmal nocturnal hemoglobinuria using routine complete blood count and cell population data

    ... marker. METHODS: We analyzed 979 complete blood counts (CBC) data from 963 patients including 57 data from 44 PNH ... were followed: flow cytometry for CD55 and CD59 on red blood cells (RBCs) to a detection level of 1%; and fluorescent aerolysin, ...

    Research Article last updated 03/02/2015 - 11:39am.

  6. Erythropoiesis-stimulating agents are not associated with increased risk of thrombosis in patients with myelodysplastic syndromes

    ... catheter placement (ORadj=6.47, 95% CI: 2.37, 17.62) and red blood cell transfusion (ORadj=4.60, 95% CI: 2.29, 9.23) were associated ...

    Research Article last updated 12/05/2011 - 10:09am.

  7. Prognostic value of self-reported fatigue on overall survival in patients with myelodysplastic syndromes: a multicentre, prospective, observational, cohort study

    ... dependency (defined as having received at least one red blood cell transfusion every 8 weeks over a period of 4 months), Eastern ...

    Research Article last updated 11/10/2015 - 10:47am.

  8. Short- and long-term benefits of lenalidomide treatment in patients with lower-risk del(5q) myelodysplastic syndromes

    ... that lenalidomide is effective not only in reducing red blood cell (RBC) transfusion burden, but also in modifying the disease ...

    Research Article last updated 12/08/2015 - 1:06pm.

  9. Efficacy and safety of extended dosing schedules of CC-486 (oral azacitidine) in patients with lower-risk myelodysplastic syndromes

    ... Overall Response (complete or partial remission, red blood cell [RBC] or platelet transfusion independence [TI], or ...

    Research Article last updated 12/09/2015 - 8:56am.

  10. Rasha Iqbal's Transplant Experience Amplifies Her Desire for Research Career

    ... mosquito bite. While scratching the bite, I discovered red spots on my skin called petechiae . They started appearing all over my hands and feet. After a trip to the doctor, a blood test, and a bone marrow biopsy , my doctor confirmed her ...

    Patient Chronicle last updated 11/13/2015 - 11:27am.